Skip to main content

Table 1 Characteristics of 34 patients with synchronous primary gastrointestinal tract carcinoma and other solid malignancies

From: MDCT diagnosis of synchronous primary gastrointestinal tract carcinoma and other solid malignancies: case series study

Case no Age/sex Colonic carcinoma Extra-colonic malignancy
TNM staging Site TNM staging
Colonic carcinoma
1 68/F T4a N1b M0 IIIB Renal T1a N0 M0 I
2 68/M T4a N1b M0 IIIB Renal T1b N0 M0 I
3 58/M T4a N2b M0 IIIC Renal T1a N0 M0 I
4 65/F T3 N1a M0 IIIB Renal T1a N0 M0 I
5 67/M T4a N2a M0 IIIC Renal T1b N0 M0 I
6 54/F T4a N2b M0 IIIB Breast T2 N0 M0 IIA
7 65/F T4a N2b M1C IVC Breast T2 N0 M0 IIA
8 60/F T4b N0 M0 IIC Breast Recurrent metastatic breast cancer
9 65/F T4a N0 M0 IIB HCC A (BCLC staging)
10 66/M T3 N1 M0 IIIB HCC C (BCLC staging)
11 64/F T4b N1 M0 IIIC HCC C (BCLC staging)
12 76/M T3 N2a M0 IIIB Prostate T3a N0 M0 IIIB
13 82/M T3 N0 M0 IIA Prostate T2c N0 M0 IIC
14 71/M T4a N0 M0 IIB Prostate T2c N0 M0 IIC
15 52/M T3 N2a M0 IIIB UB T3b N0 M0 IIIA
16 74/M T3 N0 M0 IIA UB T3b N0 M0 IIIA
17 52/F T3 N2a M1a IVA Ovarian Local recurrent
18 65/F T3 N2a M1a IVA Ovarian I (FIGO staging)
19 53/F T4a N0 M0 IIB Endo IB (FIGO staging)
20 66/F T4a N1 M0 IIIB Endo IIIC1 (FIGO staging)
21 69/M T4a N1 M1a IVA NHL III (Ann Arbor Staging)
22 60/F T2 N2a M0 IIIB HD II (Ann Arbor Staging)
23 68/M T4a N2a M0 IIIC Thyroid T3a N1b M0 II
24 66/F T3 N0 M0 IIA Lung T1c N2 M0 IIIA
  Age/sex Stomach Extra-gastric malignancy
TNM staging Site TNM staging
Gastric carcinoma
25 65/F T3 N0 M0 IIA HCC B (BCLC staging)
26 66/F T3 N3 M1 IV Breast T4b N2a M0 IIIB
27 75/F T3 N2 M0 IIB Breast T3 N1 M0 IIIA
28 66/F T4a N3a M0 IIIC NHL II (Ann Arbor Staging)
29 58/M T3 N0 M0 IIA HD I (Ann Arbor Staging)
30 60/F T3 N0 M1 IV Endo Ib (FIGO staging)
  Age/sex Periampullary Extra-periampullary malignancy
TNM staging Site TNM staging
T N M Stage   T N M Stage
Carcinoma
31 65/F T3b N0 M0 IIB UB T2b N0 M0 II
32 80/M T3b N0 M0 IIB UB T3b N0 M0 IIIA
33 74/M T1 N0 M0 IA Renal T1a N0 M0 I
  Neuroendocrine
34 64/F T2 N0 M0 II Breast T4b N2a M0 IIIA
  1. BCLC: Barcelona Clinic Liver Cancer staging classification, Endo.: Endometrial carcinoma, FIGO: the International Federation of Gynecology and Obstetrics, HCC: hepatocellular carcinoma, HD: Hodgkin disease, NHL: Non-Hodgkin lymphoma, RCC: renal cell carcinoma, UB: urinary bladder